These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11795401)

  • 1. Drug-resistant tuberculosis in Africa.
    Mwinga A
    Ann N Y Acad Sci; 2001 Dec; 953():106-12. PubMed ID: 11795401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical management of adults and children with multidrug-resistant and extensively drug-resistant tuberculosis.
    Dheda K; Chang KC; Guglielmetti L; Furin J; Schaaf HS; Chesov D; Esmail A; Lange C
    Clin Microbiol Infect; 2017 Mar; 23(3):131-140. PubMed ID: 27756712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs.
    Zumla A; Abubakar I; Raviglione M; Hoelscher M; Ditiu L; McHugh TD; Squire SB; Cox H; Ford N; McNerney R; Marais B; Grobusch M; Lawn SD; Migliori GB; Mwaba P; O'Grady J; Pletschette M; Ramsay A; Chakaya J; Schito M; Swaminathan S; Memish Z; Maeurer M; Atun R
    J Infect Dis; 2012 May; 205 Suppl 2():S228-40. PubMed ID: 22476720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa.
    Streicher EM; Müller B; Chihota V; Mlambo C; Tait M; Pillay M; Trollip A; Hoek KG; Sirgel FA; Gey van Pittius NC; van Helden PD; Victor TC; Warren RM
    Infect Genet Evol; 2012 Jun; 12(4):686-94. PubMed ID: 21839855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug- and isoniazid-resistant tuberculosis in three high HIV burden African regions.
    Sanchez-Padilla E; Ardizzoni E; Sauvageot D; Ahoua L; Martin A; Varaine F; Adatu-Engwau F; Akeche G; Salaniponi F; Bonnet M
    Int J Tuberc Lung Dis; 2013 Aug; 17(8):1036-42. PubMed ID: 23827027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of Primary Multidrug-Resistant Tuberculosis, Vladimir Region, Russia.
    Ershova JV; Volchenkov GV; Kaminski DA; Somova TR; Kuznetsova TA; Kaunetis NV; Cegielski JP; Kurbatova EV
    Emerg Infect Dis; 2015 Nov; 21(11):2048-51. PubMed ID: 26488585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multiple drug resistance: a threat for tuberculosis control].
    Cardoso EM
    Rev Panam Salud Publica; 2004 Jul; 16(1):68-73. PubMed ID: 15333267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of multidrug-resistant tuberculosis].
    Tritar F; Daghfous H; Ben Saad S; Slim-Saidi L
    Rev Pneumol Clin; 2015; 71(2-3):130-9. PubMed ID: 25153927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia.
    Mekonnen F; Tessema B; Moges F; Gelaw A; Eshetie S; Kumera G
    BMC Infect Dis; 2015 Oct; 15():461. PubMed ID: 26503269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-resistant mycobacterium tuberculosis; some data from Sweden, Estonia and Ethiopia.
    Hoffner SE
    Scand J Infect Dis Suppl; 1995; 98():17-8. PubMed ID: 8867172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.
    van Maaren PJ
    Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug resistant tuberculosis].
    Zwolska Z; Augustynowicz-Kopeć E
    Pol Merkur Lekarski; 2011 May; 30(179):362-6. PubMed ID: 21675144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.
    Pablos-Mendez A; Gowda DK; Frieden TR
    Bull World Health Organ; 2002; 80(6):489-95; discussion 495-500. PubMed ID: 12132008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-resistant tuberculosis in the WHO European Region: an analysis of surveillance data.
    Zignol M; Dara M; Dean AS; Falzon D; Dadu A; Kremer K; Hoffmann H; Hoffner S; Floyd K
    Drug Resist Updat; 2013 Dec; 16(6):108-15. PubMed ID: 24631052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of tuberculosis and multidrug resistant tuberculosis in the Middle East Region.
    Ahmad S; Mokaddas E; Al-Mutairi NM
    Expert Rev Anti Infect Ther; 2018 Sep; 16(9):709-721. PubMed ID: 30173588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug-resistant TB in Zambia: review of national data from 2000 to 2011.
    Kapata N; Chanda-Kapata P; Bates M; Mwaba P; Cobelens F; Grobusch MP; Zumla A
    Trop Med Int Health; 2013 Nov; 18(11):1386-91. PubMed ID: 24033538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia.
    Floyd K; Hutubessy R; Kliiman K; Centis R; Khurieva N; Jakobowiak W; Danilovits M; Peremitin G; Keshavjee S; Migliori GB
    Eur Respir J; 2012 Jul; 40(1):133-42. PubMed ID: 22362862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Status of drug resistance in tuberculosis after the introduction of rifampicin in India.
    Paramasivan CN
    J Indian Med Assoc; 2003 Mar; 101(3):154-6. PubMed ID: 14603961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium tuberculosis Complex Drug Resistance in a High Tuberculosis Incidence Area from the WHO Eastern Mediterranean Region.
    Mansoori N; Douraghi M; Rajabloo AA; Taziki M; Yaseri M; Vaziri F
    J Pharm Pharm Sci; 2017; 20(1):428-434. PubMed ID: 29197427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of multidrug resistant tuberculosis.
    Daley CL; Caminero JA
    Semin Respir Crit Care Med; 2013 Feb; 34(1):44-59. PubMed ID: 23460005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.